Q32 Bio EBITDA vs. Shares Outstanding
| QTTB Stock | 26.92 1.83 7.29% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -86.5 M | Current Value -90.8 M | Quarterly Volatility 41.4 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.67 | 0.5 |
|
|
For Q32 Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Q32 Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Q32 Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Q32 Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Q32 Bio over time as well as its relative position and ranking within its peers.
Q32 |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Q32 Bio. If investors know Q32 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Q32 Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.50) | Revenue Per Share (1.24) |
The market value of Q32 Bio is measured differently than its book value, which is the value of Q32 that is recorded on the company's balance sheet. Investors also form their own opinion of Q32 Bio's value that differs from its market value or its book value, called intrinsic value, which is Q32 Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Q32 Bio's market value can be influenced by many factors that don't directly affect Q32 Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Q32 Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Q32 Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Q32 Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Q32 Bio Shares Outstanding vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Q32 Bio's current stock value. Our valuation model uses many indicators to compare Q32 Bio value to that of its competitors to determine the firm's financial worth. Q32 Bio is currently regarded as top stock in ebitda category among its peers. It also is currently regarded as top stock in shares outstanding category among its peers . At present, Q32 Bio's EBITDA is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Q32 Bio's earnings, one of the primary drivers of an investment's value.Q32 Shares Outstanding vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Q32 Bio |
| = | (86.5 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Q32 Bio |
| = | 12.06 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Q32 Shares Outstanding Comparison
Q32 Bio is currently under evaluation in shares outstanding category among its peers.
Q32 Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Q32 Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Q32 Bio will eventually generate negative long term returns. The profitability progress is the general direction of Q32 Bio's change in net profit over the period of time. It can combine multiple indicators of Q32 Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -5 K | -5.2 K | |
| Operating Income | -92.1 M | -96.7 M | |
| Income Before Tax | -87.1 M | -91.4 M | |
| Total Other Income Expense Net | 5 M | 5.3 M | |
| Net Loss | -113 M | -107.3 M | |
| Income Tax Expense | 25.9 M | 27.2 M | |
| Net Loss | -38.5 M | -40.5 M | |
| Net Loss | (35.16) | (36.91) | |
| Income Quality | 0.85 | 0.52 | |
| Net Income Per E B T | 1.30 | 0.88 |
Q32 Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Q32 Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Q32 Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Q32 Bio's important profitability drivers and their relationship over time.
Use Q32 Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Q32 Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Q32 Bio will appreciate offsetting losses from the drop in the long position's value.Q32 Bio Pair Trading
Q32 Bio Pair Trading Analysis
The ability to find closely correlated positions to Q32 Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Q32 Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Q32 Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Q32 Bio to buy it.
The correlation of Q32 Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Q32 Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Q32 Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Q32 Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Q32 Bio position
In addition to having Q32 Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Driverless Cars Thematic Idea Now
Driverless Cars
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For information on how to trade Q32 Stock refer to our How to Trade Q32 Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
To fully project Q32 Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Q32 Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Q32 Bio's income statement, its balance sheet, and the statement of cash flows.